Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07028255 · ClinicalTrials.gov registry record · NA
Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels
A NA study, sponsored by Qualia Life Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07028255 is a NA study that has not yet begun recruiting, run by Qualia Life Sciences. The registered enrollment target is 60 participants.
The verdict
NCT07028255, a NA study, has not yet begun recruiting, sponsored by Qualia Life Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled parallel trial designed to assess the efficacy of Qualia Testosterone, a novel dietary supplement, in adult males aged 28 to 65 experiencing symptoms associated with testosterone deficiency. Approximately 60 participants will be randomized to receive either Qualia Testosterone (2 capsules daily) or a matched placebo for 21 days, with dosing administered each morning. The study's primary outcomes are changes in total testosterone, free testosterone (via dialysis), and dihydrotestosterone levels from baseline to Week 3. Secondary outcomes include changes in Aging Male Symptoms Scale scores-encompassing psychological, somatic, and sexual domains-as well as safety and tolerability. Blood samples will be collected in a laboratory setting, while symptom and safety assessments will be completed electronically at home.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Qualia Testosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07028255
The ClinicalTrials.gov registry entry for NCT07028255 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qualia Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07028255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07028255 about?
NCT07028255 is a clinical study titled "Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels". This is a randomized, double-blind, placebo-controlled parallel trial designed to assess the efficacy of Qualia Testosterone, a novel dietary supplement, in adult males aged 28 to 65 experiencing symptoms associated with testosterone deficiency. Approximately 60 participants will be randomized to re...
What is the current status of trial NCT07028255?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-07-01. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT07028255?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Qualia Testosterone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07028255?
This trial is sponsored by Qualia Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.